Diagnostic delay and histopathological subtyping challenges in idiopathic multicentric Castleman disease, not otherwise specified: a case report of a three-hospital odyssey - Top-Institutions - MDSpire

Challenges in Diagnosis and Histopathological Classification of Idiopathic Multicentric Castleman Disease: A Case Study Involving Multiple Healthcare Facilities

  • By

  • Fen Zhang

  • Nan Wang

  • Ying-yu Wang

  • Ye Peng

  • Yan-chen Bao

  • Hua-zheng Shi

  • Qian-wen Xiao

  • Xiao-li Zhang

  • Xiao-xi Wang

  • Chun-mei Liao

  • Jing Pan

  • Wei-qiang Teng

  • July 20, 2026

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    our hospital
    our hospital

    Unknown, Unknown

    Key Differentiators

    • Hematology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, China

    Key Differentiators

    • Hematology

  • #4

    local hospital
    local hospital

    Unknown, Unknown

    Key Differentiators

    • General Medicine

  • #5

    another municipal hospital
    another municipal hospital

    Unknown, Unknown

    Key Differentiators

    • General Medicine

Original Source(s)

Diagnostic delay and histopathological subtyping challenges in idiopathic multicentric Castleman disease, not otherwise specified: a case report of a three-hospital odyssey

  • by Fen Zhang, Nan Wang, Ying-yu Wang, Ye Peng, Yan-chen Bao, Hua-zheng Shi, Qian-wen Xiao, Xiao-li Zhang, Xiao-xi Wang, Chun-mei Liao, Jing Pan, Wei-qiang Teng

  • July 20, 2026

Related Content

Case Report: Chronic myeloid leukemia masquerading as essential thrombocythemia in a child: the imperative for early BCR::ABL1 testing in isolated thrombocytosis

Intravenous versus oral tranexamic acid in shoulder arthroplasty

Impact of high-fat Western diet on chronic lymphocytic leukemia disease progression and gut microbiome profile in Eµ-TCL1 mice